FDA

Fabry disease
Biotech

Cash-strapped Sangamo seeks partner for new gene therapy

Sangamo Therapeutics’ investigational gene therapy appears to improve kidney function at 52 weeks for patients with a rare genetic disorder.
Gabrielle Masson Jun 24, 2025 11:53am
An artists illustration of a neuron with electrical pulses used here to illustrate nerve conduction in neuropathy

Tissium snags FDA de novo clearance for sutureless nerve repair

Jun 24, 2025 11:45am
FDA
Favicon Fierce Pharma

FDA's acting CDER head heads for the exit: report

Jun 23, 2025 1:48pm
China United States politics

FDA blocks new clinical trials that ship cells from US to China

Jun 20, 2025 10:30am
Reorganization team change restructure

Industry disappointed as FDA reportedly puts Verdun on leave

Jun 20, 2025 1:53am
Clock in front of the subway

FDA 'on track' to meet all PDUFA dates, Marty Makary says

Jun 18, 2025 4:00am